Literature DB >> 29715138

Comparing Image-guided targeted Biopsies to Radical Prostatectomy Specimens for Accurate Characterization of the Index Tumor in Prostate Cancer.

Francesco Porpiglia1, Stefano DE Luca2, Enrico Checcucci2, Diletta Garrou2, Matteo Manfredi2, Fabrizio Mele2, Angela Pecoraro2, Roberto Passera3, Enrico Bollito4, Cristian Fiori2.   

Abstract

AIM: To evaluate the accuracy of multiparametric magnetic resonance-transrectal ultrasound fusion targeted biopsy (TBx) in the characterization of the index tumor, as confirmed by association with radical prostatectomy (RP) specimens. PATIENTS AND METHODS: A total of 152 patients with TBx-confirmed prostate cancer (PCa) underwent robot-assisted RP. Stained whole-mount histological sections were used as the reference standard. All lesions with a volume >0.5 ml and/or pathological Gleason score (GS) >6 were defined as clinically significant PCa. The index lesion was defined as the largest tumor focus within the prostate gland.
RESULTS: The pathological index tumours included: 147 lesions (96.7%) with a volume >0.5 ml and five (3.3%) with a volume ≤0.5 ml, but with a pathological GS ≥7; 135 (88.8%) were located in the peripheral zone. TBx accuracy in the detection of the correct site of the index lesion by reference standard was 82.2%. Sensitivity, specificity, positive and negative predictive value were: 82.3%, 50.4%, 82.8% and 49.7%, respectively. The primary/secondary Gleason grade and GS of the 152 index tumors were properly estimated in 130 (85.5%), 115 (75.6%) and 127 (83.6%) cases, respectively. The concordance of TBx with pathological GS was 83.6%. The rate of up-grading and down-grading of TBx Gleason sum was 12.2% and 4.2%, respectively.
CONCLUSION: TBx has a high sensitivity for characterization of index lesions, with a good concordance for topographic and Gleason grading accuracy between biopsy and surgical specimens. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Gleason score; Prostate cancer; index tumor; magnetic resonance imaging; radical prostatectomy; targeted-prostate biopsy

Mesh:

Year:  2018        PMID: 29715138     DOI: 10.21873/anticanres.12560

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.

Authors:  Antonio C Westphalen; Charles E McCulloch; Jordan M Anaokar; Sandeep Arora; Nimrod S Barashi; Jelle O Barentsz; Tharakeswara K Bathala; Leonardo K Bittencourt; Michael T Booker; Vaughn G Braxton; Peter R Carroll; David D Casalino; Silvia D Chang; Fergus V Coakley; Ravjot Dhatt; Steven C Eberhardt; Bryan R Foster; Adam T Froemming; Jurgen J Fütterer; Dhakshina M Ganeshan; Mark R Gertner; Lori Mankowski Gettle; Sangeet Ghai; Rajan T Gupta; Michael E Hahn; Roozbeh Houshyar; Candice Kim; Chan Kyo Kim; Chandana Lall; Daniel J A Margolis; Stephen E McRae; Aytekin Oto; Rosaleen B Parsons; Nayana U Patel; Peter A Pinto; Thomas J Polascik; Benjamin Spilseth; Juliana B Starcevich; Varaha S Tammisetti; Samir S Taneja; Baris Turkbey; Sadhna Verma; John F Ward; Christopher A Warlick; Andrew R Weinberger; Jinxing Yu; Ronald J Zagoria; Andrew B Rosenkrantz
Journal:  Radiology       Date:  2020-04-21       Impact factor: 11.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.